Hikma Pharmaceuticals Plc Director/PDMR Shareholding (4403C)

TIDMHIK

RNS Number : 4403C

Hikma Pharmaceuticals Plc

13 April 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 
1   Details of the person discharging managerial 
     responsibilities / person closely associated 
    -------------------------------------------------------------- 
a)  Name                  Michael Raya 
    --------------------  ---------------------------------------- 
2   Reason for the notification 
    -------------------------------------------------------------- 
a)  Position/status       CEO of West-Ward Pharmaceuticals 
    --------------------  ---------------------------------------- 
b)  Initial notification  Initial notification 
     /Amendment 
    --------------------  ---------------------------------------- 
3   Details of the issuer, emission allowance market 
     participant, auction platform, auctioneer or 
     auction monitor 
    -------------------------------------------------------------- 
a)  Name                  Hikma Pharmaceuticals PLC 
    --------------------  ---------------------------------------- 
b)  LEI                   549300BNS685UXH4JI75 
    --------------------  ---------------------------------------- 
4   Details of the transaction(s): section to be 
     repeated for (i) each type of instrument; (ii) 
     each type of transaction; (iii) each date; 
     and (iv) each place where transactions have 
     been conducted 
    -------------------------------------------------------------- 
a)  Description           Description: Ordinary shares of 10 
     of the financial      pence each (Shares) 
     instrument,           ID Code: GB00B0LCW083 
     type of instrument 
     and identification 
     code 
    --------------------  ---------------------------------------- 
b)  Nature of             Further Shares disposed from vesting 
     the transaction       of the conditional awards on 10 April 
                           2017 under the 2014 Executive Incentive 
                           Plan (EIP). An additional 2,370 shares 
                           were sold to cover tax and associated 
                           costs resulting in 9,383 shares being 
                           retained. 
    --------------------  ---------------------------------------- 
c)  Price(s) and           Price       Volume(s) 
     volume(s)             ----------  ---------- 
                            GBP19.42    2,370 
                           ----------  ---------- 
                            GBP0.00     9,383 
                           ----------  ---------- 
    --------------------  ---------------------------------------- 
d)  Aggregated            GBP19.42 
     information           GBP46,025 
    --------------------  ---------------------------------------- 
e)  Date of the           12 April 2017 
     transaction 
    --------------------  ---------------------------------------- 
f)  Place of the          London Stock Exchange (XLON) 
     transaction 
    --------------------  ---------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGRGDSLUBBGRX

(END) Dow Jones Newswires

April 13, 2017 03:58 ET (07:58 GMT)